Initial Treatment of Primary Open-Angle Glaucoma
Initial treatment of primary open-angle glaucoma is intraocular pressure (IOP) reduction with an IOP-lowering strategy. [1] First-choice initial medical therapy is a prostaglandin analog unless contraindicated or not tolerated. [1,2] Laser trabeculoplasty is also an accepted initial treatment option for many patients. [3]
Medication Selection Algorithm
First-line topical IOP-lowering therapy:
- Prostaglandin analogs (examples: latanoprost, travoprost, bimatoprost, tafluprost). [1,2]
Common alternative initial medication classes (used when prostaglandin analogs are contraindicated, not tolerated, or insufficient):
- Beta-adrenergic blockers (examples: timolol, betaxolol). [2]
- Topical carbonic anhydrase inhibitors (examples: dorzolamide, brinzolamide). [2]
- Alpha-agonists (examples: brimonidine). [2]
Key Evidence Supporting This Recommendation
Prostaglandin analogs are identified as first-choice or first-line therapy in major guideline documents, including European Glaucoma Society treatment principles. [2] Prostaglandin analogs have an established role as preferred initial IOP-lowering drops in contemporary clinical guidance. [1]
Monotherapy Versus Combination Therapy
Initial therapy is typically a single IOP-lowering agent (monotherapy) when clinically feasible. [1,2] Escalation beyond initial monotherapy is performed when target IOP is not achieved or when prostaglandin analogs are not tolerated. [1,2]
Important Clarifications and Nuances
Prostaglandin analogs are generally preferred over older first-line classes such as beta-blockers due to their role as first-choice/first-line therapy in guideline recommendations. [2] Contraindications and intolerance should direct selection away from prostaglandin analogs. [1]
Initiation Thresholds or Indications
Initial treatment is recommended to reduce IOP for primary open-angle glaucoma as the primary therapeutic goal. [3] Treatment is typically initiated promptly after diagnosis to prevent progression risk associated with inadequate IOP reduction. [3]
Common Pitfalls to Avoid
A common pitfall is reliance on non–IOP-lowering measures alone, since initial primary treatment goals focus on IOP reduction. [3] Another common pitfall is delaying escalation when initial therapy fails to reach the intended IOP reduction goal. [1]
Target Goals of Therapy
Target IOP is individualized based on baseline IOP, optic nerve status, and disease severity as part of ongoing management. [1]
Practical Initial Choice
Prostaglandin analogs are the gold-standard initial medical therapy choice for primary open-angle glaucoma when medication is selected as the initial approach. [1,2] Laser trabeculoplasty is an initial option that is included among initial treatment approaches in high-level evidence reviews. [3]